hydroxyurea has been researched along with Growth Disorders in 2 studies
Growth Disorders: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We performed a secondary analysis of participants in the Primary Prevention of Stroke in Children with Sickle Cell Disease in Nigeria trial, a double-blind, parallel-group randomized controlled trial for low-dose or moderate-dose hydroxyurea in children with abnormal transcranial Doppler velocities and a comparison group of participants with nonelevated transcranial Doppler velocities in northern Nigeria." | 5.69 | Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting. ( Abdullahi, SU; Acra, S; DeBaun, MR; Gambo, S; Klein, LJ; Rodeghier, M; Stallings, VA, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klein, LJ | 3 |
| Abdullahi, SU | 3 |
| Gambo, S | 3 |
| Stallings, VA | 3 |
| Acra, S | 3 |
| Rodeghier, M | 3 |
| DeBaun, MR | 3 |
1 trial available for hydroxyurea and Growth Disorders
| Article | Year |
|---|---|
Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting.
Topics: Anemia, Sickle Cell; Body Mass Index; Child; Child, Preschool; Growth Disorders; Humans; Hydroxyurea | 2023 |
Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting.
Topics: Anemia, Sickle Cell; Body Mass Index; Child; Child, Preschool; Growth Disorders; Humans; Hydroxyurea | 2023 |
Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting.
Topics: Anemia, Sickle Cell; Body Mass Index; Child; Child, Preschool; Growth Disorders; Humans; Hydroxyurea | 2023 |
Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting.
Topics: Anemia, Sickle Cell; Body Mass Index; Child; Child, Preschool; Growth Disorders; Humans; Hydroxyurea | 2023 |
Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting.
Topics: Anemia, Sickle Cell; Body Mass Index; Child; Child, Preschool; Growth Disorders; Humans; Hydroxyurea | 2023 |
Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting.
Topics: Anemia, Sickle Cell; Body Mass Index; Child; Child, Preschool; Growth Disorders; Humans; Hydroxyurea | 2023 |
Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting.
Topics: Anemia, Sickle Cell; Body Mass Index; Child; Child, Preschool; Growth Disorders; Humans; Hydroxyurea | 2023 |
Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting.
Topics: Anemia, Sickle Cell; Body Mass Index; Child; Child, Preschool; Growth Disorders; Humans; Hydroxyurea | 2023 |
Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting.
Topics: Anemia, Sickle Cell; Body Mass Index; Child; Child, Preschool; Growth Disorders; Humans; Hydroxyurea | 2023 |
1 other study available for hydroxyurea and Growth Disorders
| Article | Year |
|---|---|
Drugs for asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta | 2000 |